Events

Springboard Enterprises’ 13th Annual Winners’ Circle Dinner
Sheila Mikhail – CEO, President, Co-Founder

AskBio CEO Sheila Mikhail was recognized at Springboard Enterprises’ 13th Annual Winners’ Circle Dinner in New York City on October 23rd, as the 2019 Northstar honoree. The award is given annually to high-performing woman business entrepreneurs who are transforming their industries. Springboard’s mission is to accelerate the growth of entrepreneurial companies led by women through access to essential resources and a global community of experts.

Chardan Genetic Medicines Conference
Sheila Mikhail – CEO, President, Co-Founder

AskBio CEO Sheila Mikhail presented at the 3rd annual Chardan Genetic Medicines Conference in New York on October 7, 2019. As one of 60 private and publicly traded companies invited to participate, AskBio was the only one with an end-to-end gene therapy platform. Sheila’s presentation was viewed by leading bioscience and major pharma companies as well as researchers and academics from around the globe.

Cell & Gene Meeting on the Mesa 
Sheila Mikhail – CEO, President, Co-Founder

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference, bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Sheila Mikhail, CEO, of AskBio presented our differentiating capabilities, technology and therapeutic pipeline.  Also attending was David Venables, who served as Synpromics president and now will lead our AskBio European operations.

Harvard Career Fair
Dee Commodore – Talent Specialist
Andy Holt – Vice President of Business Development
Candace Summerford – Chief Patent Officer
Pamela Ghosh – Patent Specialist

Dee Commodore, Andy Holt, Candace Summerford, and Pamela Ghosh represented AskBio at the annual Harvard Career Fair presented by the GSAS Harvard Biotech Club. The event was well-attended and we enjoyed meeting some amazing up-and-coming talent. Andy Holt, VP of Business Development provided a compelling overview of our company to inspire many who are looking to enter the field of gene therapy.

National Limb Girdle Muscular Dystrophy Conference
Joy Carson – AskBio’s Vice President of Clinical Development & Operations
Sharon Hesterlee, PhD – EVP Portfolio Development

Joy Carson, AskBio’s Vice President of Clinical Development & Operations, and Sharon Hesterlee, AskBio’s Executive Vice President Portfolio Development, joined patients, families and leading stakeholders at the first-annual National Limb Girdle Muscular Dystrophy Conference in support of the LGMD patient community in Chicago. The event was attended by the nation’s leading neurologists in Limb Girdle Muscular Dystrophy along with leading biotech companies on the cutting edge of emerging research.

Parent Project Muscular Dystrophy, 25th Annual Conference
Jude Samulski – Co-Founder
Sharon Hesterlee, PhD – EVP Portfolio Development

AskBio’s Jude Samulski and Sharon Hesterlee joined the 25th Parent Project Muscular Dystrophy in Orlando. Families, physicians, researchers, caregivers, industry partners, and those living with Duchenne gathered to discuss the latest research and policies surrounding the disease. AskBio is proud to be part of the conversation and is working hard to support gene therapy treatment.

The Growing Promise of Gene Therapy Approaches
Josh Grieger, PhD – Chief Technology Officer

Gene Therapy Panel (Alliance for Regenerative Medicine) 
Andy Holt – VP of Business Development

American Society of Gene & Cell Therapy, 22nd Annual Conference
Martin K. (Casey) Childers, DO, PhD – Chief Medical Officer

(On right) AskBio’s Chief Medical Officer Martin K. (Casey) Childers, DO, PhD at the 22nd Annual Conference of the American Society of Gene & Cell Therapy. Dr. Childers was instrumental in developing the pre-clinical studies in the canine model and working with the Joshua Frase Foundation to perfect cutting-edge regenerative medicine to change the lives of children suffering from rare disease.